| Year |
Citation |
Score |
| 2024 |
Liubomirski Y, Tiram G, Scomparin A, Gnaim S, Das S, Gholap S, Ge L, Yeini E, Shelef O, Zauberman A, Berger N, Kalimi D, Toister-Achituv M, Schröter C, Dickgiesser S, ... ... Satchi-Fainaro R, et al. Potent antitumor activity of anti-HER2 antibody-topoisomerase I inhibitor conjugate based on self-immolative dendritic dimeric-linker. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 38228272 DOI: 10.1016/j.jconrel.2024.01.025 |
0.323 |
|
| 2023 |
Matos AI, Peres C, Carreira B, Moura LIF, Acúrcio RC, Vogel T, Wegener E, Ribeiro F, Afonso MB, Santos FMF, Martínez-Barriocanal Á, Arango D, Viana AS, Góis PMP, Silva LC, ... ... Satchi-Fainaro R, et al. Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid Tumors. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2300299. PMID 37434063 DOI: 10.1002/advs.202300299 |
0.314 |
|
| 2023 |
Ofek P, Yeini E, Arad G, Danilevsky A, Pozzi S, Luna CB, Dangoor SI, Grossman R, Ram Z, Shomron N, Brem H, Hyde TM, Geiger T, Satchi-Fainaro R. Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short-term vs long-term survivors of glioblastoma. International Journal of Cancer. PMID 37141410 DOI: 10.1002/ijc.34545 |
0.31 |
|
| 2022 |
Epshtein Y, Blau R, Pisarevsky E, Koshrovski-Michael S, Ben-Shushan D, Pozzi S, Shenbach-Koltin G, Fridrich L, Buzhor M, Krivitsky A, Dey P, Satchi-Fainaro R. Polyglutamate-based nanoconjugates for image-guided surgery and post-operative melanoma metastases prevention. Theranostics. 12: 6339-6362. PMID 36168618 DOI: 10.7150/thno.72941 |
0.774 |
|
| 2021 |
Krivitsky A, Pozzi S, Yeini E, Israeli Dangoor S, Zur T, Golan S, Krivitsky V, Albeck N, Pisarevsky E, Ofek P, Madi A, Satchi-Fainaro R. Sulfonated Amphiphilic Poly(α)glutamate Amine-A Potential siRNA Nanocarrier for the Treatment of Both Chemo-Sensitive and Chemo-Resistant Glioblastoma Tumors. Pharmaceutics. 13. PMID 34959480 DOI: 10.3390/pharmaceutics13122199 |
0.331 |
|
| 2021 |
Neufeld L, Yeini E, Reisman N, Shtilerman Y, Ben-Shushan D, Pozzi S, Madi A, Tiram G, Eldar-Boock A, Ferber S, Grossman R, Ram Z, Satchi-Fainaro R. Microengineered perfusable 3D-bioprinted glioblastoma model for in vivo mimicry of tumor microenvironment. Science Advances. 7. PMID 34407932 DOI: 10.1126/sciadv.abi9119 |
0.302 |
|
| 2020 |
Pisarevsky E, Blau R, Epshtein Y, Ben-Shushan D, Eldar-Boock A, Tiram G, Koshrovski-Michael S, Scomparin A, Pozzi S, Krivitsky A, Shenbach-Koltin G, Yeini E, Fridrich L, White R, Satchi-Fainaro R. Rational Design of Polyglutamic Acid Delivering an Optimized Combination of Drugs Targeting Mutated BRAF and MEK in Melanoma. Advanced Therapeutics. 3. PMID 35754977 DOI: 10.1002/adtp.202000028 |
0.695 |
|
| 2019 |
Zinger A, Koren L, Adir O, Poley M, Alyan M, Yaari Z, Noor N, Krinsky N, Simon A, Gibori H, Krayem M, Mumblat Y, Kasten S, Ofir S, Fridman E, ... ... Satchi-Fainaro R, et al. Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors. Acs Nano. PMID 31503443 DOI: 10.1021/Acsnano.9B02395 |
0.44 |
|
| 2019 |
Doron H, Amer M, Ershaid N, Blazquez R, Shani O, Lahav TG, Cohen N, Adler O, Hakim Z, Pozzi S, Scomparin A, Cohen J, Yassin M, Monteran L, Grossman R, ... ... Satchi-Fainaro R, et al. Inflammatory Activation of Astrocytes Facilitates Melanoma Brain Tropism via the CXCL10-CXCR3 Signaling Axis. Cell Reports. 28: 1785-1798.e6. PMID 31412247 DOI: 10.1016/J.Celrep.2019.07.033 |
0.339 |
|
| 2019 |
Malfanti A, Scomparin A, Pozzi S, Gibori H, Krivitsky A, Blau R, Satchi-Fainaro R, Mastrotto F, Caliceti P, Salmaso S. Oligo-guanidyl targeted bioconjugates forming rod shaped polyplexes as a new nanoplatform for oligonucleotide delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 310: 58-73. PMID 31400381 DOI: 10.1016/J.Jconrel.2019.08.005 |
0.315 |
|
| 2019 |
Conniot J, Scomparin A, Peres C, Yeini E, Pozzi S, Matos AI, Kleiner R, Moura LIF, Zupančič E, Viana AS, Doron H, Gois PMP, Erez N, Jung S, Satchi-Fainaro R, et al. Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators. Nature Nanotechnology. PMID 31384037 DOI: 10.1038/S41565-019-0512-0 |
0.327 |
|
| 2018 |
Krivitsky A, Krivitsky V, Polyak D, Scomparin A, Eliyahu S, Gibori H, Yeini E, Pisarevsky E, Blau R, Satchi-Fainaro R. Molecular Weight-Dependent Activity of Aminated Poly(α)glutamates as siRNA Nanocarriers. Polymers. 10. PMID 30966582 DOI: 10.3390/Polym10050548 |
0.741 |
|
| 2018 |
Blau R, Epshtein Y, Pisarevsky E, Tiram G, Israeli Dangoor S, Yeini E, Krivitsky A, Eldar-Boock A, Ben-Shushan D, Gibori H, Scomparin A, Green O, Ben-Nun Y, Merquiol E, Doron H, ... ... Satchi-Fainaro R, et al. Image-guided surgery using near-infrared Turn-ON fluorescent nanoprobes for precise detection of tumor margins. Theranostics. 8: 3437-3460. PMID 30026858 DOI: 10.7150/thno.23853 |
0.759 |
|
| 2018 |
Sainz V, Moura LIF, Peres C, Matos AI, Viana AS, Wagner AM, Vela Ramirez JE, Barata T, Gaspar M, Brocchini S, Zloh M, Peppas NA, Satchi-Fainaro R, Florindo HF. α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effectin melanoma. Acta Biomaterialia. PMID 29940370 DOI: 10.1016/J.Actbio.2018.06.029 |
0.393 |
|
| 2018 |
Tiram G, Ferber S, Ofek P, Eldar-Boock A, Ben-Shushan D, Yeini E, Krivitsky A, Blatt R, Almog N, Henkin J, Amsalem O, Yavin E, Cohen G, Lazarovici P, Lee JS, ... ... Satchi-Fainaro R, et al. Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastoma. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201701568R. PMID 29856660 DOI: 10.1096/Fj.201701568R |
0.417 |
|
| 2018 |
Shabat D, Gnaim S, Scomparin A, Das S, Satchi-Fainaro R. Real-Time Monitoring of Prodrug Activation by Direct-Mode of Chemiluminescence. Angewandte Chemie (International Ed. in English). PMID 29786931 DOI: 10.1002/Anie.201804816 |
0.328 |
|
| 2018 |
Vossen LI, Markovsky E, Eldar-Boock A, Tschiche HR, Wedepohl S, Pisarevsky E, Satchi-Fainaro R, Calderón M. PEGylated dendritic polyglycerol conjugate targeting NCAM-expressing neuroblastoma: Limitations and challenges. Nanomedicine : Nanotechnology, Biology, and Medicine. 14: 1169-1179. PMID 29471169 DOI: 10.1016/J.Nano.2018.02.009 |
0.78 |
|
| 2018 |
Eilon-Shaffer T, Roth-Konforti M, Eldar-Boock A, Satchi-Fainaro R, Shabat D. ortho-Chlorination of phenoxy 1,2-dioxetane yields superior chemiluminescent probes for in vitro and in vivo imaging. Organic & Biomolecular Chemistry. PMID 29451576 DOI: 10.1039/C8Ob00087E |
0.346 |
|
| 2018 |
Zupančič E, Curato C, Kim JS, Yeini E, Porat Z, Viana AS, Globerson-Levin A, Waks T, Eshhar Z, Moreira JN, Satchi-Fainaro R, Eisenbach L, Jung S, Florindo HF. Nanoparticulate vaccine inhibits tumor growth via improved T cell recruitment into melanoma and huHER2 breast cancer. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 29306001 DOI: 10.1016/J.Nano.2017.12.011 |
0.374 |
|
| 2018 |
Gibori H, Eliyahu S, Krivitsky A, Ben-Shushan D, Epshtein Y, Tiram G, Blau R, Ofek P, Lee JS, Ruppin E, Landsman L, Barshack I, Golan T, Merquiol E, Blum G, ... Satchi-Fainaro R, et al. Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer. Nature Communications. 9: 16. PMID 29295989 DOI: 10.1038/S41467-017-02283-9 |
0.38 |
|
| 2017 |
Krivitsky A, Polyak D, Scomparin A, Eliyahu S, Ofek P, Tiram G, Kalinski H, Avkin-Nachum S, Gracia NF, Albertazzi L, Satchi-Fainaro R. Amphiphilic poly(α)glutamate polymeric micelles for systemic administration of siRNA to tumors. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 29127036 DOI: 10.1016/J.Nano.2017.10.012 |
0.444 |
|
| 2017 |
Ferber S, Tiram G, Sousa-Herves A, Eldar-Boock A, Krivitsky A, Scomparin A, Yeini E, Ofek P, Ben-Shushan D, Vossen LI, Licha K, Grossman R, Ram Z, Henkin J, Ruppin E, ... ... Satchi-Fainaro R, et al. Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome. Elife. 6. PMID 28976305 DOI: 10.7554/Elife.25281 |
0.452 |
|
| 2017 |
Scomparin A, Florindo HF, Tiram G, Ferguson EL, Satchi-Fainaro R. Two-step polymer- and liposome- enzyme prodrug therapies for cancer: PDEPT and PELT concepts and future perspectives. Advanced Drug Delivery Reviews. PMID 28916497 DOI: 10.1016/J.Addr.2017.09.011 |
0.386 |
|
| 2017 |
Satchi-Fainaro R, Vicent MJ, Richardson S. Professor Ruth Duncan: A Pioneer in the Field of Polymer Therapeutics. Journal of Drug Targeting. 1-3. PMID 28832230 DOI: 10.1080/1061186X.2017.1371722 |
0.347 |
|
| 2017 |
Eldar-Boock A, Blau R, Ryppa C, Baabur-Cohen H, Many A, Vicent MJ, Kratz F, Sanchis J, Satchi-Fainaro R. Integrin-Targeted Nano-Sized Polymeric Systems for Paclitaxel Conjugation: A Comparative Study. Journal of Drug Targeting. 1-41. PMID 28737432 DOI: 10.1080/1061186X.2017.1358727 |
0.468 |
|
| 2017 |
Markovsky E, Vax E, Ben-Shushan D, Eldar-Boock A, Shukrun R, Yeini E, Barshack I, Caspi R, Harari-Steinberg O, Pode-Shakked N, Dekel B, Satchi-Fainaro R. Wilms Tumor NCAM-Expressing Cancer Stem Cells as Potential Therapeutic Target for Polymeric Nanomedicine. Molecular Cancer Therapeutics. 16: 2462-2472. PMID 28729402 DOI: 10.1158/1535-7163.Mct-17-0184 |
0.5 |
|
| 2017 |
Ferguson EL, Scomparin A, Hailu H, Satchi-Fainaro R. HPMA Copolymer-phospholipase C and Dextrin-Phospholipase A2 as Model Triggers for Polymer Enzyme Liposome Therapy (PELT). Journal of Drug Targeting. 1-33. PMID 28728446 DOI: 10.1080/1061186X.2017.1358726 |
0.357 |
|
| 2017 |
Ofek P, Tiram G, Satchi-Fainaro R. Angiogenesis regulation by nanocarriers bearing RNA interference. Advanced Drug Delivery Reviews. 119: 3-19. PMID 28163106 DOI: 10.1016/J.Addr.2017.01.008 |
0.355 |
|
| 2017 |
Markovsky E, Eldar-Boock A, Ben-Shushan D, Baabur-Cohen H, Yeini E, Pisarevsky E, Many A, Aviel-Ronen S, Barshack I, Satchi-Fainaro R. Targeting NCAM-expressing neuroblastoma with polymeric precision nanomedicine. Journal of Controlled Release : Official Journal of the Controlled Release Society. 249: 162-172. PMID 28159518 DOI: 10.1016/J.Jconrel.2017.01.044 |
0.784 |
|
| 2017 |
Ferber S, Tiram G, Sousa-Herves A, Eldar-Boock A, Krivitsky A, Scomparin A, Yeini E, Ofek P, Ben-Shushan D, Vossen LI, Licha K, Grossman R, Ram Z, Henkin J, Ruppin E, ... ... Satchi-Fainaro R, et al. Author response: Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome Elife. DOI: 10.7554/Elife.25281.027 |
0.416 |
|
| 2016 |
Alishekevitz D, Gingis-Velitski S, Kaidar-Person O, Gutter-Kapon L, Scherer SD, Raviv Z, Merquiol E, Ben-Nun Y, Miller V, Rachman-Tzemah C, Timaner M, Mumblat Y, Ilan N, Loven D, Hershkovitz D, ... Satchi-Fainaro R, et al. Macrophage-Induced Lymphangiogenesis and Metastasis following Paclitaxel Chemotherapy Is Regulated by VEGFR3. Cell Reports. 17: 1344-1356. PMID 27783948 DOI: 10.1016/J.Celrep.2016.09.083 |
0.407 |
|
| 2016 |
Shatsberg Z, Zhang X, Ofek P, Malhotra S, Krivitsky A, Scomparin A, Tiram G, Calderón M, Haag R, Satchi-Fainaro R. Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 27569663 DOI: 10.1016/J.Jconrel.2016.08.029 |
0.351 |
|
| 2016 |
Gnaim S, Scomparin A, Li X, Baran PS, Rader C, Satchi-Fainaro R, Shabat D. Tagging the Untaggable: A Difluoroalkyl-Sulfinate Ketone-Based Reagent for Direct C-H Functionalization of Bioactive Heteroarenes. Bioconjugate Chemistry. PMID 27494153 DOI: 10.1021/Acs.Bioconjchem.6B00382 |
0.327 |
|
| 2016 |
Blau R, Krivitsky A, Epshtein Y, Satchi-Fainaro R. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine? Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 27: 39-58. PMID 27449597 DOI: 10.1016/J.Drup.2016.06.003 |
0.355 |
|
| 2016 |
Krivitsky A, Polyak D, Scomparin A, Eliyahu S, Ori A, Avkin Nachum S, Krivitsky V, Satchi-Fainaro R. Structure-function correlation of aminated poly(α)glutamate as siRNA nanocarriers. Biomacromolecules. PMID 27377188 DOI: 10.1021/Acs.Biomac.6B00555 |
0.376 |
|
| 2016 |
Baabur-Cohen H, Vossen L, Krüger HR, Eldar-Boock A, Yeini E, Landa-Rouben N, Tiram G, Wedepohl S, Markovsky E, Leor J, Calderón M, Satchi-Fainaro R. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 27374630 DOI: 10.1016/J.Jconrel.2016.06.037 |
0.469 |
|
| 2016 |
Polyak D, Krivitsky A, Scomparin A, Eliyahu S, Kalinski H, Avkin-Nachum S, Satchi-Fainaro R. Systemic delivery of siRNA by aminated poly(α)glutamate for the treatment of solid tumors. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 27356019 DOI: 10.1016/J.Jconrel.2016.06.034 |
0.499 |
|
| 2016 |
Ofek P, Calderón M, Mehrabadi FS, Krivitsky A, Ferber S, Tiram G, Yerushalmi N, Kredo-Russo S, Grossman R, Ram Z, Haag R, Satchi-Fainaro R. Restoring the Oncosuppressor Activity of MicroRNA-34a in Glioblastoma Using a Polyglycerol-based Polyplex. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 27262933 DOI: 10.1016/J.Nano.2016.05.016 |
0.346 |
|
| 2016 |
Schwartz H, Blacher E, Amer M, Livneh N, Abramovitz L, Klein A, Ben-Shushan D, Soffer S, Blazquez R, Barrantes-Freer A, Müller M, Müller-Decker K, Stein R, Tsarfaty G, Satchi-Fainaro R, et al. Incipient melanoma brain metastases instigate astrogliosis and neuroinflammation. Cancer Research. PMID 27261506 DOI: 10.1158/0008-5472.Can-16-0485 |
0.307 |
|
| 2016 |
Golan M, Feinshtein V, Polyak D, Scomparin A, Satchi-Fainaro R, David A. Inhibition of Gene Expression and Cancer Cell Migration by CD44v3/6-Targeted Polyion Complexes. Bioconjugate Chemistry. 27: 947-60. PMID 26974863 DOI: 10.1021/Acs.Bioconjchem.6B00020 |
0.478 |
|
| 2016 |
Tiram G, Segal E, Krivitsky A, Shreberk-Hassidim R, Ofek P, Ferber S, Udagawa T, Edry L, Shomron N, Roniger M, Kerem B, Shaked Y, Aviel-Ronen S, Barshack I, Calderon M, ... ... Satchi-Fainaro R, et al. Identification of Dormancy-Associated MicroRNAs for the Design of Osteosarcoma-Targeted Dendritic Polyglycerol Nanopolyplexes. Acs Nano. PMID 26815014 DOI: 10.1021/Acsnano.5B06189 |
0.415 |
|
| 2016 |
Ofek P, Dromi N, Yerushalmi N, Kredo-Russo S, Grossman R, Ram Z, Satchi-Fainaro R. Abstract B05: Patient-derived GBM tumors versus patient-derived primary cells and GBM cell lines: lessons from microRNA profiling Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pdx16-B05 |
0.379 |
|
| 2016 |
Schwartz H, Blacher E, Amer M, Livneh N, Klein A, Ben-Shushan D, Soffer S, Stein R, Satchi-Fainaro R, Umansky V, Pukrop T, Erez N. Abstract C26: Melanoma brain metastasis is facilitated by instigation of reactive astrogliosis Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-C26 |
0.343 |
|
| 2016 |
Tiram G, Ofek P, Udagawa T, Shomron N, Roniger M, Kerem B, Shaked Y, Aviel-Ronen S, Barshack I, Calderon M, Haag R, Satchi-Fainaro R. Abstract B42: Dysregulation of key microRNAs controlling tumor-host interactions triggers escape from osteosarcoma dormancy Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-B42 |
0.377 |
|
| 2016 |
Tiram G, Ferber S, Satchi-Fainaro R. Abstract B39: Identifying molecular signatures of tumor dormancy as a basis for the rational design of precision nanomedicines Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-B39 |
0.474 |
|
| 2015 |
Scomparin A, Polyak D, Krivitsky A, Satchi-Fainaro R. Achieving successful delivery of oligonucleotides--From physico-chemical characterization to in vivo evaluation. Biotechnology Advances. 33: 1294-309. PMID 25916823 DOI: 10.1016/J.Biotechadv.2015.04.008 |
0.388 |
|
| 2015 |
Scomparin A, Salmaso S, Eldar-Boock A, Ben-Shushan D, Ferber S, Tiram G, Shmeeda H, Landa-Rouben N, Leor J, Caliceti P, Gabizon A, Satchi-Fainaro R. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index. Journal of Controlled Release : Official Journal of the Controlled Release Society. 208: 106-20. PMID 25869964 DOI: 10.1016/J.Jconrel.2015.04.009 |
0.453 |
|
| 2015 |
Bonzi G, Salmaso S, Scomparin A, Eldar-Boock A, Satchi-Fainaro R, Caliceti P. Novel pullulan bioconjugate for selective breast cancer bone metastases treatment. Bioconjugate Chemistry. 26: 489-501. PMID 25613006 DOI: 10.1021/Bc500614B |
0.31 |
|
| 2014 |
Ben-Shushan D, Markovsky E, Gibori H, Tiram G, Scomparin A, Satchi-Fainaro R. Overcoming obstacles in microRNA delivery towards improved cancer therapy. Drug Delivery and Translational Research. 4: 38-49. PMID 25786616 DOI: 10.1007/S13346-013-0160-0 |
0.302 |
|
| 2014 |
Ferber S, Tiram G, Satchi-Fainaro R. Monitoring functionality and morphology of vasculature recruited by factors secreted by fast-growing tumor-generating cells. Journal of Visualized Experiments : Jove. e51525. PMID 25490071 DOI: 10.3791/51525 |
0.366 |
|
| 2014 |
Markovsky E, Baabur-Cohen H, Satchi-Fainaro R. Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs. Journal of Controlled Release : Official Journal of the Controlled Release Society. 187: 145-57. PMID 24862318 DOI: 10.1016/J.Jconrel.2014.05.025 |
0.438 |
|
| 2014 |
Kisin-Finfer E, Ferber S, Blau R, Satchi-Fainaro R, Shabat D. Synthesis and evaluation of new NIR-fluorescent probes for cathepsin B: ICT versus FRET as a turn-ON mode-of-action. Bioorganic & Medicinal Chemistry Letters. 24: 2453-8. PMID 24767838 DOI: 10.1016/J.Bmcl.2014.04.022 |
0.331 |
|
| 2014 |
Tiram G, Scomparin A, Ofek P, Satchi-Fainaro R. Interfering cancer with polymeric siRNA nanomedicines. Journal of Biomedical Nanotechnology. 10: 50-66. PMID 24724498 DOI: 10.1166/Jbn.2014.1715 |
0.413 |
|
| 2014 |
Ferber S, Baabur-Cohen H, Blau R, Epshtein Y, Kisin-Finfer E, Redy O, Shabat D, Satchi-Fainaro R. Polymeric nanotheranostics for real-time non-invasive optical imaging of breast cancer progression and drug release. Cancer Letters. 352: 81-9. PMID 24614283 DOI: 10.1016/J.Canlet.2014.02.022 |
0.401 |
|
| 2014 |
Eldar-Boock A, Ben-Shushan D, Sanchis J, Lupu R, Vicent MJ, Satchi-Fainaro R. Abstract LB-196: Preventing breast cancer metastases with an anti-angiogenic and anticancer RGD-bearing nanomedicine Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-196 |
0.462 |
|
| 2014 |
Ferber S, Tiram G, Amsalem O, Yavin E, Almog N, Henkin J, Calderon M, Haag R, Satchi-Fainaro R. Abstract LB-104: Reverting the angiogenic switch of glioblastoma with a nanopolyplex based on the molecular fingerprint of tumor dormancy Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-104 |
0.448 |
|
| 2014 |
Ofek P, Calderon M, Sheikhi-Mehrabadi F, Ferber S, Haag R, Satchi-Fainaro R. Abstract 4391: Multi-modal nanomedicine for glioblastoma Cancer Research. 74: 4391-4391. DOI: 10.1158/1538-7445.Am2014-4391 |
0.38 |
|
| 2014 |
Tiram G, Ferber S, Ofek P, Shomron N, Udagawa T, Aviel-Ronen S, Barshack I, Satchi-Fainaro R. Abstract 4219: miR-34a, miR-93 and miR-200c - novel molecular regulators of osteosarcoma dormancy Cancer Research. 74: 4219-4219. DOI: 10.1158/1538-7445.Am2014-4219 |
0.333 |
|
| 2013 |
Eldar-Boock A, Polyak D, Scomparin A, Satchi-Fainaro R. Nano-sized polymers and liposomes designed to deliver combination therapy for cancer. Current Opinion in Biotechnology. 24: 682-9. PMID 23726153 DOI: 10.1016/J.Copbio.2013.04.014 |
0.43 |
|
| 2013 |
Miller K, Clementi C, Polyak D, Eldar-Boock A, Benayoun L, Barshack I, Shaked Y, Pasut G, Satchi-Fainaro R. Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases. Biomaterials. 34: 3795-806. PMID 23434349 DOI: 10.1016/J.Biomaterials.2013.01.052 |
0.407 |
|
| 2013 |
Benayoun L, Schaffer M, Bril R, Gingis-Velitski S, Segal E, Nevelsky A, Satchi-Fainaro R, Shaked Y. Porfimer-sodium (Photofrin-II) in combination with ionizing radiation inhibits tumor-initiating cell proliferation and improves glioblastoma treatment efficacy Cancer Biology and Therapy. 14: 64-74. PMID 23114641 DOI: 10.4161/Cbt.22630 |
0.429 |
|
| 2013 |
Herzog IM, Feldman M, Eldar-Boock A, Satchi-Fainaro R, Fridman M. Design of membrane targeting tobramycin-based cationic amphiphiles with reduced hemolytic activity Medchemcomm. 4: 120-124. DOI: 10.1039/C2Md20162C |
0.347 |
|
| 2013 |
Polyak D, Eldar-Boock A, Baabur-Cohen H, Satchi-Fainaro R. Polymer conjugates for focal and targeted delivery of drugs Polymers For Advanced Technologies. 24: 777-790. DOI: 10.1002/Pat.3158 |
0.469 |
|
| 2012 |
Satchi-Fainaro R, Ferber S, Segal E, Ma L, Dixit N, Ijaz A, Hlatky L, Abdollahi A, Almog N. Prospective identification of glioblastoma cells generating dormant tumors. Plos One. 7: e44395. PMID 22970208 DOI: 10.1371/Journal.Pone.0044395 |
0.432 |
|
| 2012 |
Benayoun L, Gingis-Velitski S, Voloshin T, Segal E, Segev R, Munster M, Bril R, Satchi-Fainaro R, Scherer SJ, Shaked Y. Tumor-initiating cells of various tumor types exhibit differential angiogenic properties and react differently to antiangiogenic drugs. Stem Cells (Dayton, Ohio). 30: 1831-41. PMID 22782858 DOI: 10.1002/Stem.1170 |
0.449 |
|
| 2012 |
Markovsky E, Baabur-Cohen H, Eldar-Boock A, Omer L, Tiram G, Ferber S, Ofek P, Polyak D, Scomparin A, Satchi-Fainaro R. Administration, distribution, metabolism and elimination of polymer therapeutics. Journal of Controlled Release : Official Journal of the Controlled Release Society. 161: 446-60. PMID 22286005 DOI: 10.1016/J.Jconrel.2011.12.021 |
0.364 |
|
| 2012 |
Ofek P, Fischer W, Calderon M, Haag R, Satchi-Fainaro R. Abstract 5650: Targeting siRNA to tumors and their stroma as a dual anticancer and anti-angiogenic therapy Cancer Research. 72: 5650-5650. DOI: 10.1158/1538-7445.Am2012-5650 |
0.441 |
|
| 2012 |
Ferber S, Segal E, Almog N, Satchi-Fainaro R. Abstract 5238: Impaired angiogenesis as a hallmark of prolonged tumor dormancy in a mouse model of human glioblastoma Cancer Research. 72: 5238-5238. DOI: 10.1158/1538-7445.Am2012-5238 |
0.376 |
|
| 2012 |
Tiram G, Segal E, Sherberk R, Bachar G, Ofek P, Udagawa T, Edry L, Shomron N, Satchi-Fainaro R. Abstract 5235: Uncovering tumor-host molecular and cellular interactions involved in tumor dormancy using microRNAs Cancer Research. 72: 5235-5235. DOI: 10.1158/1538-7445.Am2012-5235 |
0.398 |
|
| 2012 |
Eldar-Boock A, Sanchis J, Lupu R, Vicent MJ, Satchi-Fainaro R. Abstract 5225: Correlation between αvβ3 integrin expression, paclitaxel resistance and RGD-bearing conjugate efficacy Cancer Research. 72: 5225-5225. DOI: 10.1158/1538-7445.Am2012-5225 |
0.505 |
|
| 2012 |
Tiram G, Segal E, Bachar G, Shreberk R, Ofek P, Satchi-Fainaro R. Abstract 4643: Shedding light on the molecular basis of tumor dormancy using antiangiogenic nanomedicines Cancer Research. 72: 4643-4643. DOI: 10.1158/1538-7445.Am2012-4643 |
0.362 |
|
| 2011 |
Karton-Lifshin N, Segal E, Omer L, Portnoy M, Satchi-Fainaro R, Shabat D. A unique paradigm for a Turn-ON near-infrared cyanine-based probe: noninvasive intravital optical imaging of hydrogen peroxide. Journal of the American Chemical Society. 133: 10960-5. PMID 21631116 DOI: 10.1021/Ja203145V |
0.301 |
|
| 2011 |
Clementi C, Miller K, Mero A, Satchi-Fainaro R, Pasut G. Dendritic poly(ethylene glycol) bearing paclitaxel and alendronate for targeting bone neoplasms. Molecular Pharmaceutics. 8: 1063-72. PMID 21608527 DOI: 10.1021/Mp2001445 |
0.424 |
|
| 2011 |
Miller K, Eldar-Boock A, Polyak D, Segal E, Benayoun L, Shaked Y, Satchi-Fainaro R. Antiangiogenic antitumor activity of HPMA copolymer-paclitaxel-alendronate conjugate on breast cancer bone metastasis mouse model. Molecular Pharmaceutics. 8: 1052-62. PMID 21545170 DOI: 10.1021/Mp200083N |
0.483 |
|
| 2011 |
Segal E, Pan H, Benayoun L, Kopečková P, Shaked Y, Kopeček J, Satchi-Fainaro R. Enhanced anti-tumor activity and safety profile of targeted nano-scaled HPMA copolymer-alendronate-TNP-470 conjugate in the treatment of bone malignances. Biomaterials. 32: 4450-63. PMID 21429572 DOI: 10.1016/J.Biomaterials.2011.02.059 |
0.436 |
|
| 2011 |
Eldar-Boock A, Miller K, Sanchis J, Lupu R, Vicent MJ, Satchi-Fainaro R. Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel Biomaterials. 32: 3862-3874. PMID 21376390 DOI: 10.1016/J.Biomaterials.2011.01.073 |
0.51 |
|
| 2011 |
Scomparin A, Salmaso S, Bersani S, Satchi-Fainaro R, Caliceti P. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 42: 547-58. PMID 21371555 DOI: 10.1016/J.Ejps.2011.02.012 |
0.383 |
|
| 2011 |
Polyak D, Ryppa C, Eldar-Boock A, Ofek P, Many A, Licha K, Kratz F, Satchi-Fainaro R. Development of PEGylated doxorubicin-E-[c(RGDfK)2] conjugate for integrin-targeted cancer therapy Polymers For Advanced Technologies. 22: 103-113. DOI: 10.1002/Pat.1731 |
0.456 |
|
| 2010 |
Marom H, Miller K, Bechor-Bar Y, Tsarfaty G, Satchi-Fainaro R, Gozin M. Toward development of targeted nonsteroidal antiandrogen-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-gadolinium complex for prostate cancer diagnostics. Journal of Medicinal Chemistry. 53: 6316-25. PMID 20715870 DOI: 10.1021/Jm100289B |
0.316 |
|
| 2010 |
Ofek P, Fischer W, Calderón M, Haag R, Satchi-Fainaro R. In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers The Faseb Journal. 24: 3122-3134. PMID 20385622 DOI: 10.1096/Fj.09-149641 |
0.448 |
|
| 2009 |
Segal E, Satchi-Fainaro R. Design and development of polymer conjugates as anti-angiogenic agents. Advanced Drug Delivery Reviews. 61: 1159-76. PMID 19699248 DOI: 10.1016/J.Addr.2009.06.005 |
0.483 |
|
| 2009 |
Erez R, Segal E, Miller K, Satchi-Fainaro R, Shabat D. Enhanced cytotoxicity of a polymer-drug conjugate with triple payload of paclitaxel. Bioorganic & Medicinal Chemistry. 17: 4327-35. PMID 19482477 DOI: 10.1016/J.Bmc.2009.05.028 |
0.41 |
|
| 2009 |
Segal E, Pan H, Ofek P, Udagawa T, Kopecková P, Kopecek J, Satchi-Fainaro R. Targeting angiogenesis-dependent calcified neoplasms using combined polymer therapeutics. Plos One. 4: e5233. PMID 19381291 DOI: 10.1371/Journal.Pone.0005233 |
0.463 |
|
| 2009 |
Miller K, Erez R, Segal E, Shabat D, Satchi-Fainaro R. Targeting bone metastases with a bispecific anticancer and antiangiogenic polymer-alendronate-taxane conjugate. Angewandte Chemie (International Ed. in English). 48: 2949-54. PMID 19294707 DOI: 10.1002/Anie.200805133 |
0.38 |
|
| 2009 |
Stern L, Perry R, Ofek P, Many A, Shabat D, Satchi-Fainaro R. A novel antitumor prodrug platform designed to be cleaved by the endoprotease legumain. Bioconjugate Chemistry. 20: 500-10. PMID 19196156 DOI: 10.1021/Bc800448U |
0.434 |
|
| 2009 |
Ryppa C, Mann-Steinberg H, Biniossek ML, Satchi-Fainaro R, Kratz F. In vitro and in vivo evaluation of a paclitaxel conjugate with the divalent peptide E-[c(RGDfK)2] that targets integrin alpha v beta 3. International Journal of Pharmaceutics. 368: 89-97. PMID 18992308 DOI: 10.1016/J.Ijpharm.2008.09.055 |
0.345 |
|
| 2007 |
Chesler L, Goldenberg DD, Seales IT, Satchi-Fainaro R, Grimmer M, Collins R, Struett C, Nguyen KN, Kim G, Tihan T, Bao Y, Brekken RA, Bergers G, Folkman J, Weiss WA. Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma. Cancer Research. 67: 9435-42. PMID 17909053 DOI: 10.1158/0008-5472.Can-07-1316 |
0.439 |
|
| 2007 |
Nahari D, Satchi-Fainaro R, Chen M, Mitchell I, Task LB, Liu Z, Kihneman J, Carroll AB, Terada LS, Nwariaku FE. Tumor cytotoxicity and endothelial Rac inhibition induced by TNP-470 in anaplastic thyroid cancer. Molecular Cancer Therapeutics. 6: 1329-37. PMID 17431111 DOI: 10.1158/1535-7163.Mct-06-0554 |
0.383 |
|
| 2007 |
Sagi A, Segal E, Satchi-Fainaro R, Shabat D. Remarkable drug-release enhancement with an elimination-based AB3 self-immolative dendritic amplifier. Bioorganic & Medicinal Chemistry. 15: 3720-7. PMID 17416532 DOI: 10.1016/J.Bmc.2007.03.054 |
0.355 |
|
| 2006 |
Duncan R, Ringsdorf H, Satchi-Fainaro R. Polymer therapeutics--polymers as drugs, drug and protein conjugates and gene delivery systems: past, present and future opportunities. Journal of Drug Targeting. 14: 337-41. PMID 17092834 DOI: 10.1080/10611860600833856 |
0.316 |
|
| 2006 |
Becker CM, Wright RD, Satchi-Fainaro R, Funakoshi T, Folkman J, Kung AL, D'Amato RJ. A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy. The American Journal of Pathology. 168: 2074-84. PMID 16723720 DOI: 10.2353/Ajpath.2006.051133 |
0.303 |
|
| 2005 |
Sjin RMTT, Satchi-Fainaro R, Birsner AE, Ramanujam VMS, Folkman J, Javaherian K. A 27-amino-acid synthetic peptide corresponding to the NH 2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity Cancer Research. 65: 3656-3663. PMID 15867360 DOI: 10.1158/0008-5472.Can-04-1833 |
0.317 |
|
| 2005 |
Satchi-Fainaro R, Mamluk R, Wang L, Short SM, Nagy JA, Feng D, Dvorak AM, Dvorak HF, Puder M, Mukhopadhyay D, Folkman J. Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. Cancer Cell. 7: 251-61. PMID 15766663 DOI: 10.1016/J.Ccr.2005.02.007 |
0.385 |
|
| 2004 |
Satchi-Fainaro R, Puder M, Davies JW, Tran HT, Sampson DA, Greene AK, Corfas G, Folkman J. Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470. Nature Medicine. 10: 255-61. PMID 14981512 DOI: 10.1038/Nm1002 |
0.516 |
|
| 2003 |
Satchi-Fainaro R, Hailu H, Davies JW, Summerford C, Duncan R. PDEPT: Polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-β-lactamase and HPMA copolymer-C-Dox as a model combination Bioconjugate Chemistry. 14: 797-804. PMID 12862433 DOI: 10.1021/Bc020091K |
0.354 |
|
| 2002 |
Satchi-Fainaro R. Targeting tumor vasculature: reality or a dream? Journal of Drug Targeting. 10: 529-533. PMID 12683719 DOI: 10.1080/1061186021000051062 |
0.506 |
|
| 2002 |
Satchi-Fainaro R, Wrasidlo W, Lode HN, Shabat D. Synthesis and characterization of a catalytic antibody-HPMA copolymer-Conjugate as a tool for tumor selective prodrug activation. Bioorganic & Medicinal Chemistry. 10: 3023-9. PMID 12110325 DOI: 10.1016/S0968-0896(02)00156-6 |
0.359 |
|
| Show low-probability matches. |